Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion type Assertion NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_head.
- NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion description "[data describe percentage of bone marrow cells expressing receptors for interleukin-1, platelet-derived growth factor, fibroblast growth factor, transforming growth factor-beta, epidermal growth factor and c-Fos and c-Myc in untreated lung & breast cancer ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_provenance.
- NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion evidence source_evidence_literature NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_provenance.
- NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion SIO_000772 16305343 NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_provenance.
- NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion wasDerivedFrom lhgdn-20090331 NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_provenance.
- NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_assertion wasGeneratedBy ECO_0000203 NP214282.RAgfr2mRZm1okMzXLy2WRdzKodFK0lLgiN_kxG-ld22Ww130_provenance.